BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 17163870)

  • 21. [Long-term observation of patients with autoimmune hemolytic anemia].
    Kopeć I; Słomkowski M; Przybyszewska M; Szczepanik K; Maj S
    Acta Haematol Pol; 1991; 22(1):58-68. PubMed ID: 1823969
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Myelofibrosis, autoimmune haemolytic anaemia and Tn-polyagglutinability.
    Bird GW; Wingham J; Richardson SG
    Haematologia (Budap); 1985; 18(2):99-103. PubMed ID: 3928459
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Problems associated with compatibility testing for patients with autoimmune hemolytic anemia.
    Garratty G
    Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():76-9. PubMed ID: 7886613
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined autoimmune cytopenias.
    Martino R; Muñiz-Díaz E; Arilla M; Ibáñez M; Altés A; Guanyabens C; Madoz P
    Haematologica; 1995; 80(4):305-10. PubMed ID: 7590498
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of platelet activation in canine immune-mediated haemolytic anaemia.
    Ridyard AE; Shaw DJ; Milne EM
    J Small Anim Pract; 2010 Jun; 51(6):296-304. PubMed ID: 20618628
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rituximab in the treatment of autoimmune haematological disorders.
    Garvey B
    Br J Haematol; 2008 Apr; 141(2):149-69. PubMed ID: 18318765
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhanced IL-10 production in vitro by monocytes in autoimmune haemolytic anaemia.
    Fagiolo E; Terenzi CT
    Immunol Invest; 1999; 28(5-6):347-52. PubMed ID: 10574632
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinically significant red cell alloantibodies in patients with warm autoimmune hemolytic anemia.
    Haspl ZH; Tomicić M; Grgicević D
    Acta Med Croatica; 2001; 55(4-5):149-52. PubMed ID: 12398016
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The CD47 pathway is deregulated in human immune thrombocytopenia.
    Catani L; Sollazzo D; Ricci F; Polverelli N; Palandri F; Baccarani M; Vianelli N; Lemoli RM
    Exp Hematol; 2011 Apr; 39(4):486-94. PubMed ID: 21211546
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The 'metabolon,' CD47, and the 'phagocytic synapse': molecular co-localization and species divergence.
    Subramanian S; Tsai R; Discher DE
    Transfus Clin Biol; 2006; 13(1-2):31-8. PubMed ID: 16581280
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Generation and characterisation of Rhd and Rhag null mice.
    Goossens D; Trinh-Trang-Tan MM; Debbia M; Ripoche P; Vilela-Lamego C; Louache F; Vainchenker W; Colin Y; Cartron JP
    Br J Haematol; 2010 Jan; 148(1):161-72. PubMed ID: 19807729
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lethal autoimmune hemolytic anemia in CD47-deficient nonobese diabetic (NOD) mice.
    Oldenborg PA; Gresham HD; Chen Y; Izui S; Lindberg FP
    Blood; 2002 May; 99(10):3500-4. PubMed ID: 11986200
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro generated Rh(null) red cells recapitulate the in vivo deficiency: a model for rare blood group phenotypes and erythroid membrane disorders.
    Cambot M; Mazurier C; Canoui-Poitrine F; Hebert N; Picot J; Clay D; Picard V; Ripoche P; Douay L; Dubart-Kupperschmitt A; Cartron JP
    Am J Hematol; 2013 May; 88(5):343-9. PubMed ID: 23417980
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autoimmune haemolytic anaemia and immune thrombocytopenia following SARS-CoV-2 and non-SARS-CoV-2 vaccination: 32 Years of passive surveillance data.
    Jacobs JW; Booth GS; Guarente J; Schlafer D; Zheng L; Adkins BD
    Br J Haematol; 2023 Apr; 201(2):227-233. PubMed ID: 36564040
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of autoantigens in autoimmune haemolytic anaemia by a non-radioisotope immunoprecipitation method.
    Barker RN; Casswell KM; Reid ME; Sokol RJ; Elson CJ
    Br J Haematol; 1992 Sep; 82(1):126-32. PubMed ID: 1419786
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Autoimmune hemolytic anemia in childhood: serologic features in 100 cases.
    Vaglio S; Arista MC; Perrone MP; Tomei G; Testi AM; Coluzzi S; Girelli G
    Transfusion; 2007 Jan; 47(1):50-4. PubMed ID: 17207229
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Failure of blood mononuclear cells from human donors with autoimmune haemolytic anaemia to reconstitute severe combined immunodeficient mice.
    Macht LM; Leader KA; Corrall RJ; Yates P; Elson CJ
    Autoimmunity; 1992; 14(2):127-35. PubMed ID: 1303679
    [TBL] [Abstract][Full Text] [Related]  

  • 38. BAFF and BAFF-R of peripheral blood and spleen mononuclear cells in idiopathic thrombocytopenic purpura.
    Zhou Z; Chen Z; Li H; Chen X; Xu J; Gu D; Du W; Zheng C; Zhang L; Huang Y; Ren Q; Yang R
    Autoimmunity; 2009 Feb; 42(2):112-9. PubMed ID: 19005881
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Isolation of a peptide associated with autoimmune haemolytic anaemia from red cell membranes.
    Kajii E; Ikemoto S; Ueki J; Miura Y
    Clin Exp Immunol; 1988 Sep; 73(3):406-9. PubMed ID: 3208451
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mycophenolate mofetil for the treatment of refractory auto-immune haemolytic anaemia and auto-immune thrombocytopenia purpura.
    Howard J; Hoffbrand AV; Prentice HG; Mehta A
    Br J Haematol; 2002 Jun; 117(3):712-5. PubMed ID: 12028047
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.